SANDRA ROSENBERG: Open Payments
NPI 1710490792 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$539 in 26 payments from 12 companies in 2025. Trend: 2023 $730 · 2024 $409 · 2025 $539
Food & beverage: $539
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 9 | $161 |
| Sumitomo Pharma America, Inc. | 6 | $125 |
| Procept Biorobotics Corporation | 2 | $49 |
| Boston Scientific Corporation | 1 | $32 |
| Dendreon Pharmaceuticals LLC | 1 | $27 |
| PROGENICS PHARMACEUTICALS, INC. | 1 | $24 |
| Teleflex LLC | 1 | $23 |
| ABBVIE INC. | 1 | $23 |
| TOLMAR, INC. | 1 | $22 |
| Verity Pharmaceuticals Inc. | 1 | $20 |
Products named: ERLEADA, GEMTESA, AQUABEAM ROBOTIC SYSTEM, AdVance XP, PROVENGE, PYLARIFY, DEKNATEL, LUPRON DEPOT.
Industry payments across FL — which companies pay providers there.
